XML 25 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 6 - Investments in Joint Ventures
9 Months Ended
May 31, 2016
Notes to Financial Statements  
Equity Method Investments and Joint Ventures Disclosure [Text Block]
6. INVESTMENTS IN JOINT VENTURES
 
The financial statements of the Company’s foreign joint ventures are initially prepared using the accounting principles accepted in the respective joint ventures’ countries of domicile. Amounts related to foreign joint ventures reported in the below tables and the accompanying consolidated financial statements have subsequently been adjusted to conform with accounting principles generally accepted in the United States of America in all material respects. All material profits recorded on sales from the Company to its joint ventures and from joint ventures to other joint ventures have been eliminated for financial reporting purposes.
 
Financial information from the audited and unaudited financial statements of the Company’s joint venture in Germany, Excor Korrosionsschutz – Technologien und Produkte GmbH (EXCOR) and all of the Company’s other joint ventures, are summarized as follows:
 
    May 31, 2016
    Total   EXCOR   All Other
Current assets   $ 47,930,421     $ 22,433,723     $ 25,496,698  
Total assets     51,389,757       24,189,092       27,200,665  
Current liabilities     13,952,018       4,602,925       9,349,093  
Noncurrent liabilities     103,392             103,392  
Joint ventures’ equity     37,334,348       19,586,166       17,748,182  
Northern Technologies International Corporation’s share of joint ventures’ equity     18,604,871       9,793,085       8,811,786  
Northern Technologies International Corporation’s share of joint ventures’ undistributed earnings   $ 15,892,135     $ 9,416,694     $ 6,475,441  
 
 
    August 31, 2015
    Total   EXCOR   All Other
Current assets   $ 49,295,116     $ 22,620,323     $ 26,674,793  
Total assets     52,853,938       24,606,880       28,247,058  
Current liabilities     12,288,383       3,360,142       8,928,241  
Noncurrent liabilities     1,215,139             1,215,139  
Joint ventures’ equity     39,350,417       21,246,738       18,103,679  
Northern Technologies International Corporation’s share of joint ventures’ equity     20,544,238       11,571,361       8,972,877  
Northern Technologies International Corporation’s share of joint ventures’ undistributed earnings   $ 18,483,377     $ 11,540,456     $ 6,942,921  
 
    Nine Months Ended May 31, 2016
    Total   EXCOR   All Other
Net sales   $ 66,223,514     $ 25,314,260     $ 40,909,254  
Gross profit     29,745,795       13,512,404       16,233,391  
Net income     7,188,274       5,409,407       1,778,867  
Northern Technologies International Corporation’s share of equity in income of joint ventures   $ 3,600,884     $ 2,714,905     $ 885,979  
                         
 
    Nine Months Ended May 31, 2015
    Total   EXCOR   Tianjin
Zerust
  All Other
Net sales   $ 75,974,770     $ 27,580,051     $ 3,735,457     $ 44,659,262  
Gross profit     37,469,186       15,113,100       1,783,673       20,572,413  
Net income     9,634,318       6,334,009       265,648       3,034,661  
Northern Technologies International Corporation’s share of equity in income of joint ventures   $ 4,806,247     $ 3,152,489     $ 132,824     $ 1,520,934  
 
On January 2, 2015, the Company announced that, effective as of December 31, 2014, the Company terminated its joint venture arrangement in China, Tianjin-Zerust Anticorrosion Co., Ltd. (Tianjin Zerust), and began the process of liquidating the joint venture entity. Since December 31, 2014, the Company has conducted business in China through a wholly-owned subsidiary, NTIC (Shanghai) Co. Ltd. (NTIC China). As of December 31, 2014, the Company started recognizing Tianjin Zerust based on its carrying value instead of the equity method since the Company no longer expects to significantly affect the joint venture’s operations or decision making. See Note 7.
 
The Company records expenses that are directly attributable to the joint ventures on its consolidated statements of operations in the line item “Expenses incurred in support of joint ventures.” The expenses include items such as employee compensation and benefit expenses, travel expense and consulting expense. See Note 13 regarding pending litigation involving Tianjin Zerust.
 
The Company did not make any joint venture investments during the nine months ended May 31, 2016 and 2015.